The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options.
Delivering on our purpose is our core responsibility to our stakeholders and society in general. We are committed to achieving this in an economically, socially, and environmentally responsible manner.
We take our responsibility seriously and seek dialogue with all our stakeholders to find out what really matters to them, through efforts such as our materiality assessment, our sustainability survey, and stakeholder-specific engagement activities.
As Idorsia grows, our commitment to sustainability remains as important as ever.
From the beginning, Idorsia’s leadership has emphasized that sustainability is central to how we define our success.
Our stakeholders believe that, in order to achieve sustainable value creation, we must continue to focus our efforts on three pillars that emerged from our stakeholder engagement and materiality assessment.
Idorsia’s 2022 sustainability performance is reported in our content index, which includes an info sheet for each of our material topics summarizing key qualitative and quantitative disclosures, guided by GRI standards.